| 2 | A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies: the DACIPHOR regimen. (Karmali R, Galvez C, Hamadani M, Gordon L, Winter J, Ma S, Nelson V, Fenske TS, Shah NN, Jagadeesh D, Klein A, Helenowski I, Chen R, Mi X, Petrich A, Evens AM, Pro B) Blood Adv 2024 Apr 09;8(7):1612-1620 1 Citation |
| 1 | Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial. (Wilson N, Reese S, Ptak L, Aziz F, Parajuli S, Jucaud V, Denham S, Mishra A, Cascalho M, Platt JL, Hematti P, Djamali A) Kidney360 2023 Jun 01;4(6):e796-e808 |
| 1 | Phase Ib Study of the Oral Proteasome Inhibitor Ixazomib (MLN9708) and Fulvestrant in Advanced ER+ Breast Cancer Progressing on Fulvestrant. (Schwartz G, Shee K, Romo B, Marotti J, Kisselev A, Lewis L, Miller T) Oncologist 2021 Jun;26(6):467-e924 5 Citations |
| 11 | Ixazomib for Chronic Graft-versus-Host Disease Prophylaxis following Allogeneic Hematopoietic Cell Transplantation. (Chhabra S, Visotcky A, Pasquini MC, Zhu F, Tang X, Zhang MJ, Thompson R, Abedin S, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Douglas Rizzo J, Runaas L, Saber W, Shah NN, Shaw BE, Horowitz MM, Hari PN, Hamadani M) Biol Blood Marrow Transplant 2020 Oct;26(10):1876-1885 6 Citations |
| 4 | Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma. (Dhakal B, D'Souza A, Hamadani M, Arce-Lara C, Schroeder K, Chhabra S, Shah NN, Gauger K, Keaton T, Pasquini M, Hari P) Blood Cancer J 2019 Jul 29;9(8):56 19 Citations |
| 1 | Attenuation of cardiac ischemia-reperfusion injury by sodium thiosulfate is partially dependent on the effect of cystathione beta synthase in the myocardium. (Kannan S, Boovarahan SR, Rengaraju J, Prem P, Kurian GA) Cell Biochem Biophys 2019 Sep;77(3):261-272 17 Citations |
| 2 | Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance. (Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Rajkumar SV, Richardson PG) Leukemia 2019 Jul;33(7):1736-1746 41 Citations |
| 1 | Healthcare resource utilization with ixazomib or placebo plus lenalidomide-dexamethasone in the randomized, double-blind, phase 3 TOURMALINE-MM1 study in relapsed/refractory multiple myeloma. (Hari P, Lin HM, Zhu Y, Berg D, Richardson PG, Moreau P) J Med Econ 2018 Aug;21(8):793-798 7 Citations |
| 1 | The quest for endothelial atypical cannabinoid receptor: BKCa channels act as cellular sensors for cannabinoids in in vitro and in situ endothelial cells. (Bondarenko AI, Panasiuk O, Drachuk K, Montecucco F, Brandt KJ, Mach F) Vascul Pharmacol 2018 Mar;102:44-55 17 Citations |
| 1 | A single center phase II study of ixazomib in patients with relapsed or refractory cutaneous or peripheral T-cell lymphomas. (Boonstra PS, Polk A, Brown N, Hristov AC, Bailey NG, Kaminski MS, Phillips T, Devata S, Mayer T, Wilcox RA) Am J Hematol 2017 Dec;92(12):1287-1294 23 Citations |
| 1 | Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1. (Mateos MV, Masszi T, Grzasko N, Hansson M, Sandhu I, Pour L, Viterbo L, Jackson SR, Stoppa AM, Gimsing P, Hamadani M, Borsaru G, Berg D, Lin J, Di Bacco A, van de Velde H, Richardson PG, Moreau P) Haematologica 2017 Oct;102(10):1767-1775 47 Citations |
| 1 | Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma. (Kumar S, Moreau P, Hari P, Mateos MV, Ludwig H, Shustik C, Masszi T, Spencer A, Hájek R, Romeril K, Avivi I, Liberati AM, Minnema MC, Einsele H, Lonial S, Berg D, Lin J, Gupta N, Esseltine DL, Richardson PG) Br J Haematol 2017 Aug;178(4):571-582 59 Citations |
| 1 | Mutants of Cytochrome P450 Reductase Lacking Either Gly-141 or Gly-143 Destabilize Its FMN Semiquinone. (Rwere F, Xia C, Im S, Haque MM, Stuehr DJ, Waskell L, Kim JJ) J Biol Chem 2016 Jul 08;291(28):14639-61 22 Citations |
| 1 | Rigosertib versus best supportive care for patients with high-risk myelodysplastic syndromes after failure of hypomethylating drugs (ONTIME): a randomised, controlled, phase 3 trial. (Garcia-Manero G, Fenaux P, Al-Kali A, Baer MR, Sekeres MA, Roboz GJ, Gaidano G, Scott BL, Greenberg P, Platzbecker U, Steensma DP, Kambhampati S, Kreuzer KA, Godley LA, Atallah E, Collins R Jr, Kantarjian H, Jabbour E, Wilhelm FE, Azarnia N, Silverman LR, ONTIME study investigators) Lancet Oncol 2016 Apr;17(4):496-508 147 Citations |
| 1 | [EFFECT OF PROPARGYLGLYCINE UPON CARDIOHEMODYNAMICS IN OLD RATS]. (Drachuk KO, Dorofeyeva NA, Kotsjuruba AV, Sagach VF) Fiziol Zh (1994) 2015;61(4):35-40 2 Citations |
| 2 | Blockade of neurokinin-1 receptors in the ventral respiratory column does not affect breathing but alters neurochemical release. (Muere C, Neumueller S, Olesiak S, Miller J, Hodges MR, Pan L, Forster HV) J Appl Physiol (1985) 2015 Mar 15;118(6):732-41 6 Citations |
| 2 | Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study. (Kumar SK, Berdeja JG, Niesvizky R, Lonial S, Laubach JP, Hamadani M, Stewart AK, Hari P, Roy V, Vescio R, Kaufman JL, Berg D, Liao E, Di Bacco A, Estevam J, Gupta N, Hui AM, Rajkumar V, Richardson PG) Lancet Oncol 2014 Dec;15(13):1503-1512 250 Citations |
| 1 | [Propargylglycine restores endothelium-dependent relaxation of aortic smooth muscles in old rats]. (Drachuk KO, Kotsiuruba AV, Baziliuk OV, Stepanenko LH, Sahach VF) Fiziol Zh (1994) 2014;60(4):3-10 4 Citations |
| 1 | The memory-enhancing effects of hippocampal estrogen receptor activation involve metabotropic glutamate receptor signaling. (Boulware MI, Heisler JD, Frick KM) J Neurosci 2013 Sep 18;33(38):15184-94 170 Citations |
| 1 | A novel anti-tumor inhibitor identified by virtual screen with PLK1 structure and zebrafish assay. (Lu J, Xin S, Meng H, Veldman M, Schoenfeld D, Che C, Yan R, Zhong H, Li S, Lin S) PLoS One 2013;8(4):e53317 16 Citations |
| 1 | N-Arachidonoyl glycine suppresses Na⁺/Ca²⁺ exchanger-mediated Ca²⁺ entry into endothelial cells and activates BK(Ca) channels independently of GPCRs. (Bondarenko AI, Drachuk K, Panasiuk O, Sagach V, Deak AT, Malli R, Graier WF) Br J Pharmacol 2013 Jun;169(4):933-48 23 Citations |
| 1 | Metabotropic glutamate receptor I (mGluR1) antagonism impairs cocaine-induced conditioned place preference via inhibition of protein synthesis. (Yu F, Zhong P, Liu X, Sun D, Gao HQ, Liu QS) Neuropsychopharmacology 2013 Jun;38(7):1308-21 45 Citations |
| 2 | Atropine microdialysis within or near the pre-Botzinger Complex increases breathing frequency more during wakefulness than during NREM sleep. (Muere C, Neumueller S, Miller J, Olesiak S, Hodges MR, Pan L, Forster HV) J Appl Physiol (1985) 2013 Mar 01;114(5):694-704 15 Citations |
| 1 | Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex. (Lutgen V, Qualmann K, Resch J, Kong L, Choi S, Baker DA) Psychopharmacology (Berl) 2013 Apr;226(3):531-40 14 Citations |
| 1 | Antitumor activity of the investigational proteasome inhibitor MLN9708 in mouse models of B-cell and plasma cell malignancies. (Lee EC, Fitzgerald M, Bannerman B, Donelan J, Bano K, Terkelsen J, Bradley DP, Subakan O, Silva MD, Liu R, Pickard M, Li Z, Tayber O, Li P, Hales P, Carsillo M, Neppalli VT, Berger AJ, Kupperman E, Manfredi M, Bolen JB, Van Ness B, Janz S) Clin Cancer Res 2011 Dec 01;17(23):7313-23 94 Citations |
| 1 | Excitatory-inhibitory imbalance in hypoglossal neurons during the critical period of postnatal development in the rat. (Gao XP, Liu QS, Liu Q, Wong-Riley MT) J Physiol 2011 Apr 15;589(Pt 8):1991-2006 45 Citations |
| 1 | An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca2+ sensing. (Yang J, Krishnamoorthy G, Saxena A, Zhang G, Shi J, Yang H, Delaloye K, Sept D, Cui J) Neuron 2010 Jun 24;66(6):871-83 97 Citations |
| 1 | Analyzing the catalytic role of Asp97 in the methionine aminopeptidase from Escherichia coli. (Mitra S, Job KM, Meng L, Bennett B, Holz RC) FEBS J 2008 Dec;275(24):6248-59 8 Citations |
| 1 | Global expression profiling identifies a novel biosignature for protein aggregation R120GCryAB cardiomyopathy in mice. (Rajasekaran NS, Firpo MA, Milash BA, Weiss RB, Benjamin IJ) Physiol Genomics 2008 Oct 08;35(2):165-72 26 Citations |
| 1 | Acetylation of H4 suppresses the repressive effects of the N-termini of histones H3/H4 and facilitates the formation of positively coiled DNA. (Peterson S, Jackson V) Biochemistry 2008 Jul 08;47(27):7053-65 3 Citations |
| 1 | Changing the substrate specificity of creatine kinase from creatine to glycocyamine: evidence for a highly evolved active site. (Jourden MJ, Clarke CN, Palmer AK, Barth EJ, Prada RC, Hale RN, Fraga D, Snider MJ, Edmiston PL) Biochim Biophys Acta 2007 Dec;1774(12):1519-27 12 Citations |
| 1 | Identification of two novel mutations in families with X-linked ocular albinism. (Iannaccone A, Gallaher KT, Buchholz J, Jennings BJ, Neitz M, Sidjanin DJ) Mol Vis 2007 Oct 02;13:1856-61 4 Citations |
| 1 | Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. (Rajasekaran NS, Connell P, Christians ES, Yan LJ, Taylor RP, Orosz A, Zhang XQ, Stevenson TJ, Peshock RM, Leopold JA, Barry WH, Loscalzo J, Odelberg SJ, Benjamin IJ) Cell 2007 Aug 10;130(3):427-39 397 Citations |
| 1 | Neprilysin inhibits angiogenesis via proteolysis of fibroblast growth factor-2. (Goodman OB Jr, Febbraio M, Simantov R, Zheng R, Shen R, Silverstein RL, Nanus DM) J Biol Chem 2006 Nov 03;281(44):33597-605 42 Citations |
| 1 | Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis. (Kroner A, Vogel F, Kolb-Mäurer A, Kruse N, Toyka KV, Hemmer B, Rieckmann P, Mäurer M) J Neuroimmunol 2005 Aug;165(1-2):161-5 27 Citations |
| 1 | The yeast F(1)F(0)-ATP synthase: analysis of the molecular organization of subunit g and the importance of a conserved GXXXG motif. (Saddar S, Stuart RA) J Biol Chem 2005 Jul 01;280(26):24435-42 36 Citations |
| 1 | Reactivity of (bicyclo[5.1.0]octadienyl)iron(1+) cations: application to the synthesis of cis-2-(2'-carboxycyclopropyl)glycines. (Wallock NJ, Donaldson WA) J Org Chem 2004 Apr 30;69(9):2997-3007 15 Citations |
| 1 | Glycine 420 near the C-terminal transmembrane domain of SR-BI is critical for proper delivery and metabolism of high density lipoprotein cholesteryl ester. (Parathath S, Sahoo D, Darlington YF, Peng Y, Collins HL, Rothblat GH, Williams DL, Connelly MA) J Biol Chem 2004 Jun 11;279(24):24976-85 26 Citations |
| 1 | Iron-mediated preparation of vinylcyclopropanecarboxylates: scope, mechanism, and applications. (Yun YK, Godula K, Cao Y, Donaldson WA) J Org Chem 2003 Feb 07;68(3):901-10 37 Citations |
| 1 | A G468-T AMPD1 mutant allele contributes to the high incidence of myoadenylate deaminase deficiency in the Caucasian population. (Gross M, Rötzer E, Kölle P, Mortier W, Reichmann H, Goebel HH, Lochmüller H, Pongratz D, Mahnke-Zizelman DK, Sabina RL) Neuromuscul Disord 2002 Aug;12(6):558-65 32 Citations |
| 1 | Isoflurane preconditions myocardium against infarction via release of free radicals. (Müllenheim J, Ebel D, Frässdorf J, Preckel B, Thämer V, Schlack W) Anesthesiology 2002 Apr;96(4):934-40 151 Citations |
| 1 | A disease-associated glycine substitution in BP180 (type XVII collagen) leads to a local destabilization of the major collagen triple helix. (Olague-Marchan M, Twining SS, Hacker MK, McGrath JA, Diaz LA, Giudice GJ) Matrix Biol 2000 Jul;19(3):223-33 13 Citations |
| 1 | A study of carbobenzoxy-D-phenylalanine-L-phenylalanine-glycine, an inhibitor of membrane fusion, in phospholipid bilayers with multinuclear magnetic resonance. (Dentino AR, Westerman PW, Yeagle PL) Biochim Biophys Acta 1995 May 04;1235(2):213-20 8 Citations |
| 1 | A single amino acid substitution flanking the fourth calcium binding domain of alpha IIb prevents maturation of the alpha IIb beta 3 integrin complex. (Wilcox DA, Wautier JL, Pidard D, Newman PJ) J Biol Chem 1994 Feb 11;269(6):4450-7 84 Citations |
| 1 | Perilymphatic fistula: analysis of free amino acids in middle ear microaspirates. (Woodson BT, Fujita S, Mawhinney TP, Schweitzer VG, Peterson EL) Otolaryngol Head Neck Surg 1991 Jun;104(6):796-802 4 Citations |
© 2025 Clinical & Translational Science Institute